People are exposed to a number of environmental, occupational, and therapeutic toxic agents which may be natural or man made. These hazardous substances may manifest as direct side effects on the function of organs or indirectly induced alteration of gene expression, cancer-associated metabolic pathways, and/or alter homeostasis. Lycopene, as a one of the most potent antioxidant, is found in fruits and vegetables. High-intake of lycopene has been shown to be effective in decreasing the risk of both natural toxins including mycotoxins, bacterial toxins, and chemical toxins including heavy metals, pesticides as well as herbicides. Recently, there is growing attention in understanding the mechanisms of the phytochemicals and carotenoids as antioxidative, antiapoptotic, radical scavenging, and chelating agents and their roles in the modulation of inflammatory pathways. This review summarizes available data from several recent studies about lycopene and its role against chemical and natural toxicants.
Introduction
Lycopene, a red carotene and carotenoid pigment, is phytochemical compound found in tomatoes, watermelons, apricots, and other red fruits and vegetables. Compositions that are not red may also comprise lycopene, such as asparagus and parsley. Although lycopene is chemically a carotene, it has no vitamin A activity. It is a noncyclic carotenoid which has a molecular weight of 536. 85 Daltons and is insoluble in water. Dietary antioxidants, such as lycopene, play a role in prevention of lipid, protein, and DNA oxidation and related diseases. While lycopene is a stable molecule, it can undergo oxidative, thermal and photo-degradation [1] . The in vitro antioxidant potency of lycopene, up to 100 times more efficient than vitamin E, its chemopreventive activity [2] against certain types of cancers, and its protective activity against chemotherapeutic-induced renal damage have attracted considerable research activity in recent years [3] . Lycopene has been widely used in traditional medicine and has been reported to have protective effects on treatment of cardiovascular diseases [4] , neurotoxicity [5] , hepatic injury [6] , nephrotoxicity [7] , as an antioxidant [8] , and as an antiapoptotic agent [9] . The protective role of lycopene on toxicant induced toxicity is discussed in this review.
Natural toxins
Lycopene has been reported to exhibit protective effects against several toxins, including some mycotoxins and bacterial toxins.
Mycotoxins

Aflatoxin
The aflatoxins, significant food contaminants, are produced by Aspergillus flavus and Aspergillus parasiticus. Aflatoxin B1 (AFB1) is a genotoxic hepatocarcinogen [10] . The phase 1 metabolism of AFB1 was significantly reduced in male and female F344 rats pretreated with lycopene (100 mg/kg, orally for 3 weeks) as demonstrated by a decreased in the metabolites, AFP1, AFQ1, and AFM1, in urine suggesting that lycopene may selectively inhibits certain phase 1 cytochrome p45s such as Cyt 3A4, Cyt 2A6, and Cyt 1A2. Serum levels of AFB1-albumin adduct, levels of AFB-N7-Gua adduct in hepatic DNA and the levels of AFB-N7-Gua excreted in the urine were also significantly reduced. Excretion of AFB 1 -mercapturic acid, the phase 2 detoxification metabolite of AFB1, was significantly increased in lycopene-treated animals [11] . In another study, AFB1 (2.5 mg/kg, single dose, i.p) significantly decreased sperm motility, seminifer epithelium thickness and increased the number of abnormal sperms. The level of malondialdehyde in the testicular tissue was higher in AFB1 treated rats than in control animals. Supplementation with lycopene (10 mg/kg, orally) reduced testicular damage and the oxidative stress induced by AFB1 [12] . In addition, lycopene (10 mg/kg, orally) combined with vitamin E (10 mg/kg/day, orally) for 12 days had a protective effect against AFB1 (2.5 mg/kg on the 12th day) induced damage to the gastric mucosa in rats. The combination increased the level and function of sulphomucins (mucins with sulphate groups) while decreasing the levels of mucus and phospholipid, which are essential in the gastric mucosal barrier [13] .
Totally, these results suggest that inhibition of metabolic activation and induction of detoxification enzymes are the main mechanisms for the protective effects of lycopene against aflatoxin toxicity [11] .
Ochratoxin A
The ochratoxins are secondary metabolites of Aspergillus and Penicillium species [14] . Ochratoxin A (OTA) is a nephrotoxin, a reproductive toxicant and a possible hepatotoxin. The protective effects of lycopene against OTA (0.5 mg/kg, 14 days orally) induced DNA damage has been reported. Lycopene (5 mg/kg for given orally both 7 and 14 days) provided a significant decrease of comet tail in the kidney and liver cells versus OTA only treated rats [15] . In addition, the partially protective effect of lycopene against OTA (0.5 mg/kg/day, orally for 14 days) induced renal apoptosis and toxicity has been suggested in male Sprague-Dawley rats. Lycopene treatment (5 mg/kg/day, orally for 14 days) increased glutathione (GSH) levels and induced renal glutathione peroxidase 1 (GPx1) activity [16] . Palabiyik et al. [16] also reported that lycopene (5 mg/kg/day by gavage for 14 days) reduced the OTA induced renal oxidative stress and apoptosis in rats based on data obtained from their terminal deoxynucleotidyl transferase dUTP nick end labeling analysis which showed a decrease in apoptotic cell death.
Bacterial toxins
Lipopolysaccharide
Bacterial lipopolysaccharide (LPS), a glycolipid structure on the outer membrane of gram-negative bacteria, elicits a strong immune response in animals [17] . LPSs are responsible for inflammatory reactions (Table 1) [18] . Lycopene (5-20 μM) significantly suppressed the production of LPS (100 ng/ml) induced proinflammatory cytokines such as interleukin 1 beta (IL-1β), tumor necrosis factor alpha (TNF-α), and nitric oxide (NO) in rat primary cultured microglia. These results indicated that inhibition of the activity of microglia by lycopene may be associated with inactivation of extracellular signal-regulated kinase (ERK1/2) [18] . In addition, tomato lycopene extract (TLE) (100 μg/mL) inhibited LPS (5 μg/mL) induced gene expression in murine splenocytes through prevention of nuclear factor kappa-light-chain-enhancer of the activated B cells (NF-κB)-signaling pathway which in turn enhanced apoptosis in IEC-18 cells, which is mediated by obstruction of IkBα degradation, RelA nuclear translocation and transcription activity [19] . Lycopene (10 mg/kg, for 6 days, i.p) was effective in reducing Dgalactosamine/LPSs (D-GalN/LPS) (300 mg/kg and 30 μg/kg body weight, respectively, i.p) resulting in a change in the activity of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), and serum gamma glutamyl transferase (γ-GT) in rats [20] . Rafi and his colleagues demonstrated that LPS (0.5 μg/mL) induced NO activity was inhibited by lycopene (1.25-10 μM) through suppression of inducible nitric oxide synthase (iNOS) and mRNA expressions in a mouse macrophage cell line model (RAW 264.7) [21] . Additionally, lycopene was found to inhibit LPS-stimulated dendritic cells (DC) maturation. The mechanism by which lycopene suppressed the phenotypic and functional maturation of murine dendritic cells (BM-DC) was attenuation of mitogen-activated protein kinases (ERK1/2, p38, and JNk) and NF-κBp65 translocation [22] . It has also been reported that lycopene can inhibit the release of interleukin-6 (IL-6) and interferon-gamma induced protein-10 (IP-10) in LPS and in rhinovirus (RV) infected airway epithelial cells (Calu-3). These results suggest that lycopene has a potential role in inhibition of inflammation-induced by RV infection [23] . Lycopene also has anti-inflammatory activity on RAW 264.7 macrophages by modulating the LPS (1 ng/mL) induced expression of TNF-α. The proposed mechanisms are associated with a limit of macrophage migration, reduction of JNK and NF-κB signaling pathways, and the pro-inflammatory cytokines that are induced by macrophage conditioned medium and chemokine mRNA expression in 3 T3-L1 adipocytes [24] . Lycopene (5 mg/kg, orally) has been reported to improve LPS (6 mg/kg, i.p) induced histopathological damage, to enhance anti-oxidative properties, to decrease the expression of TNF-α and IL-6 and to inhibit the stimulation of mitogen-activated protein kinase (MAPK) and the NF-κB pathway in acute lung injury (ALI) in rats [25] . The project of Sun et al. focused on the effects of lycopene (20, 40 , or 80 mg/kg, orally for 35 days) on biochemical factors, immune organ profiles and antioxidant capacity in breeding hens after LPS (1 mg/kg, on 35th day) stimulation. LPS increased high density lipoprotein (HDL) and triidothyronine (T3), increased the glutathione to oxidized glutathione ratio (GSH/GSSG) and the immune organ (thymus, bursal, and Fabricius) index. In contrast, pretreatment with lycopene reduced total cholesterol, low density lipoprotein, and blood urea nitrogen [26] . These cell culture and animal studies show that Lycopene supplementation affects inflammatory immune response to LPS mainly via attenuation of ERK1/2, p38, JNk, and NF-κB signaling pathways [22] . The dose ranges of lycopene in in vitro and in vivo studies were 1.25-20 μM and 5-10 mg/kg respectively. In future, clinical trials in human are needed to evaluate the efficacy of lycopene in different inflammatory conditions.
Microcystin-LR
Microcystin-LRs (MC-LRs), a group of cyclic heptapeptide hepatotoxins, are produced by numerous species of cyanobacteria such as Nostoc, Oscillatoria, Microcystis, and Anabaena [27, 28] . MC-LRs act as serine/threonine protein phosphatases (PPs) inhibitors resulting in hyperphosphorylation of functional proteins [29, 30] . Supplementation with lycopene (10 mg/mouse/d, i.p. for 2 weeks) reduced ALT, total bile acids (TBA), and glutathione S-transferase (GST) and increased glycogen and GPx) following microcystin-LR (75 μg/kg, single dose, i.p.) induced toxicity in mouse liver. Consequently, lycopene supplementation may have a protective role against microcysin-induced hepatotoxicity [31] .
Other toxins
D-Galactosamine
D-galactosamine causes hepatic necrosis by reducing the pool of uridine in hepatocytes [32] which leads to inhibition of protein synthesis as well as messenger RNA (mRNA) [33] . Treatment of rats with lycopene (10 mg/kg body weight/day, i.p, for 6 days) resulted in reduction of LPS/D-galactosamine (D-GalN/ LPS) (300 mg/kg and 30 μg/kg, i.p., of D-GalN and LPS, respectively) induced oxidative stress. The protective activity of lycopene is related to suppression of lipid peroxidation. In addition, a protective effect of lycopene against D-GalN/LPS-stimulated genotoxicity by free radicals attack was also observed [34] .
Shariff et al. recorded the lipoprotein concentrations of lipid metabolizing-related enzymes, including lipoprotein lipase, hepatic triglyceride (TG) lipase, and lecithin in the blood of DGalN/LPS (300 mg/kg and 30 μg/kg, respectively, i.p., 18 h before the experiment) induced hepatitis in rats-fed lycopene (10 mg/kg body weight, i.p., for 6 days) in the diet. These results emphasized maintaining normal lipid metabolism as the basis for the anti-oxidant role of lycopene [35] .
Chemical induced toxicity
In this section, we discuss the important protective effects and mechanisms of lycopene against a variety of chemicals including metals, fluoride, pesticides, cardiotoxic, hepatotoxic, and nephrotoxic agents (Fig. 1). 
Metals
Cadmium
Cadmium is an environmental pollutant released into the atmosphere from factories, urban traffic, incineration and other industrial activities. It is deposited in the kidneys where it can induce renal toxicity if not eliminated [36] . In one study, the protective effects of lycopene (20 mg/kg body weight, i.p., for 15 days) against cadmium (0.32 mg/kg body weight, i.p, single dose) induced renal toxicity was evaluated by studying renal function in albino mice. Lycopene supplementation reduced urea and creatinine concentrations and increased glycogen, total protein and cholesterol [37] . Furthermore, lycopene (20 mg/kg body weight, i.p., for 15 days) had a protective effect against cadmium (0.32 mg/kg body weight, i.p.) induced oxidative cardiac injury. Lycopene consumption decreased infarction size and other morphological damage in cardic tissue of mice [38] . Lycopene (10 mg/kg/day, orally) also has been reported to protect against cadmium (6.6 mg/kg/day, orally, for 20 days) induced lipid peroxidation (LPO) and body weight loss in rats. A significant suppress in malondialdehyde (MDA) levels in plasma and kidney homogenates as well as body weight loss were observed in the lycopene supplemented groups [39] .
It can be concluded that lycopene acts as a potential antioxidant that prevents cadmium-induced renal and cardiac toxicity and weight loss in animal models via reducing of the oxidative stress.
Copper
Copper, an essential part of several enzymes, is found in different cells and tissues with the highest concentration in the liver. Copper toxicity can results from oxidative stress and typically is characterized by liver cirrhosis and/or injury of renal tubules [40] . Interestingly, treatment of broiler chickens with lycopene reduced triglycerides and LDL cholesterol concentration in plasma, and suppressed the oxidation of LDL induced by copper. Lycopene has a potential antioxidant activity [41] . Ghafari et al. reported that lycopene caused an increase in radical formation time in LDL and consequently reduced the susceptibility of LDL oxidation induced by copper II [42] .
BioFactors
Mercury
Mercury is an toxic and rare heavy metal which is widely dispersed in nature by industrial activities [43] . Mercury accumulates in the kidneys and can induce renal toxicity. Although lycopene protected against renal toxicity caused by mercuric chloride (5 mg/kg, body weight, s.c.) in rats by inhibiting lipid peroxidation with selected anti-oxidant enzymes and by altering δ-aminolevulinate dehydratase (ALAD) activity, lycopene (10-50 mg/kg, orally) did not suppress renal failure induced by HgCl 2 [44] . Lycopene has been reported to reduce Methyl mercury (500 nM for 12 h) induced mitochondrial oxidative stress in cultured cerebellar granule neurons (CGNs). Pre-treatment with lycopene helped maintained cell viability and reduced lactate dehydrogenase releases. ROS generation and accumulation also were reduced by lycopene in the same cell system [45] . Hepatoprotective activity of lycopene (40 mg/kg, orally) against mercuric chloride (2.2, 4.4, and 8.8 μmol/kg, s.c.) has been reported in rats including: 1] suppression of reactive oxygen species, 2] improvement of the function of superoxide dismutase (SOD) and GSH-Px, and 3] reduction of ALT, LDH, MDA, and GSH levels [43] . A micronucleus (MN) assay and histopathological examination were used to determine the protective properties of lycopene (5, 10, 15, 20 mg/kg/day) against mercury-stimulated cytotoxicity in albino mice. The results showed that mercury (10 mg/kg body weight) caused degeneration of hepatocyte, hemorrhage and degeneration of tubules in the kidneys while lycopene treatment reversed or at least reduced these effects. In addition, lycopene supplementation had a protective effect on MN at 20 mg/kg/day [46] .
Lead
Lead, a persistent toxic heavy metal, is a common industrial and environmental pollutant. Lead exposure has been shown to result in a wide variety of organ injuries, including damage to the kidneys [47, 48] . Ishiaq et al. in 2011 reported that consumption of lycopene (33 g powdered tomato in water) decreased the renal injury induced by lead in rats by improve reduced GSHactivity. A summary of the protective effects of lycopene against selected metals is provided in Table 2 .
Fluoride
Fluoride is a monatomic anion of fluorine. It is added to several consumer products including drinking water and toothpaste in many countries. In the last century, the use of fluoride in food industry has increased. Fluoride is naturally present in most seafood. Fluoride can easily pass from the plasma and is distributed in muscle and other organs [49] . Mansour et al. found that fluoride (10.3 mg/kg body weight, for 5 weeks) induced oxidative stress, reduced GSH levels, SOD activity and total anti-oxidant capacity in rats (TAC) which was normalized by supplementation with lycopene (10 mg/kg body weight, orally, for 5 weeks) most probably due to the free-radical scavenging and anti-oxidant function of lycopene [50] .
Pesticides
Pesticides are designed to kill pests and include herbicides, insecticides, rodenticides, and fungicides [51] . The extensive application of pesticides for crop protection and agricultural production can lead to public health and environmental pollution concerns.
Chlorpyrifos
Chlorpyrifos, a broad-spectrum organophosphorothioate insecticide, has been widely used in both domestic and agriculture applications [52] . Lycopene (10 mg/kg, body weight, orally) has been reported to have a protective effect against chlorpyrifos induced (0.04 mg/l, in their environment, for 14 days) changes in certain hematological factors and on the oxidant/antioxidant status of cells in fish [63] .
Diazinon
Diazinon (DZN) is a wide-spectrum organophosphate insecticide used for both agricultural and urban purposes [64] . Diazinon has been shown to induce toxicity in various organs such as the liver [53] and the nervous system [54, 55] . It was shown that a lycopene (10 mg/kg, for 14 days) and vitamin E (50 mg/kg, for 28 days) combination had a protective effect against DZN (0.76 and 2.3 mg/l) in fish. Dietary lycopene and vitamin E improved selected hematological parameters and reduced the ALP, AST, and ALT activity as well as the urea and creatinine concentrations [56] . Moreover, the lycopene (10 mg/kg, for 14 days) and vitamin E (50 mg/kg, for 28 days) combination supplied as a dietary supplementation had a protective role against diazinon toxicity (0.76 and 2.3 mg/l) in Oreochromis niloticus, a cichlid fish. Consequently, lycopene appears to exerts its effects by decreasing LPO and free-radicals in fish [57] .
Deltamethrin
Deltamethrin, a synthetic pyrethroid type II pesticide containing an α-cyano group, is used against a wide-spectrum of insects including flies and mosquitoes [58] . The potential protective effect of lycopene against deltamethrin (1.28 mg/kg/day, orally, for 30 days) induced toxicity in kidney has been reported by ElGerbed et al. Deltamethrin exposure leads to enhancement of the TNF-α factor, the number and atypical forms of mitochondria, and ultrastructural lesions in the lining of cells in the proximal tubules and changes in apical microvilli in rats. Supplementation with lycopene (1 mg/kg per day) improved these alterations in kidneys [59] . In addition, the effect of lycopene on deltamethrin-stimulated (5 mg/kg/day body weight, orally) testicular damage in rats has been assessed. Results showed that lycopene (1 mg/kg body weight) normalized body weight, serum testosterone, total testicular oxidant capacity and poly (ADPribose) polymerase (PARP) activity and reduced heat-shock protein 70 (HSP-70) mRNA and DNA injury in rats [60] . Furthermore, lycopene (10 mg/kg, orally) inhibited DNA injury and thyroid gland toxicity induced by deltamethrine (2 mg/kg body weight) in albino rats [61] . Lycopene (10 mg/kg, orally) provided as a dietary supplement, appeared to have an important role in the attenuation of deltamethrin (0.036, 0.018 μg/L, for 14 days) induced oxidative stress in Cyprinus carpio by decreasing the level of MDA and increasing SOD, CAT, and GSH-Px activities [62] .
Malathion
Malathion is an organophosphate pesticides used widely to control pests because of its low toxicity and great selectivity for insects [63] . Malathion intoxication is due to inhibition of acetylcholinesterase activity in target tissues [64] . Malathion (0.5 and 1 mg/L, for 14 days) exposure in Cyprinus carpio carpio (carp) resulted in changes in hematological parameters including red blood cell (RBC) count, hemoglobin (Hb) concentration, hematocrit (Ht) and immune responses including white blood cell (WBC) count, oxidative radical production [nitroblue tetrazolium (NBT) activity), total plasma protein (TP) and total immunoglobulin (TI) levels, and phagocytic activity (PA)] as well as inhibition of antioxidant capacity. In malathion exposed carps, treatment with lycopene (10 mg/kg) resulted in normalization of most of the above mentioned parameters [65] . Rotenone Rotenone is a crystalline isoflavone which used as a pesticide. It exists naturally in the seeds and stems of some plants [66] . It is not particularly toxic to birds, mammals and humans. In contrast, rotenone is toxic for fish and exerts its toxic effect by interfering with the mitochondrial electron transport system [10] . A Parkinson-like disease model was employed to assess the protective effect of lycopene (10 mg/kg body weight, orally) against rotenone (3 mg/kg, body weight, i.p) induced oxidative stress and neurobehavioral outcomes in C57BL/6 mice. The results from this study suggested that the beneficial effects of lycopene administration included increasing the SOD, CAT, and GSH-Px activity [67] . Similar results were reported by Kaur et al. in a rat model of Parkinson disease. Lycopene (10 mg/kg, orally, for 30 days) supply its neuroprotective activity through suppression of oxidative stress by normalizing parameters such as GSH and SOD and by activating the complex-I (NADH Dehydrogenase) that has the potential to decrease free radical production [68] . Thus, lycopene may be a candidate for treatment of certain neurobehavioral abnormalities [68, 69] .
Cypermethrin
Cypermethrin, a synthetic type II pyrethroid, widely used as an insecticide instead of organophosphorus and organochlorine to control pests [70, 71] . It has been demonstrated in Cyprinus carpio fish that the SOD, CAT, GSH-Px activity, and GSH concentration in blood and tissues were modified by cypermethrin (0.202, 0.404 μg/L in their environment for 28 days) exposure. Lycopene (10 mg/kg body weight, orally, for 28 days), a naturally antioxidant, could decrease MDA level in plasma as well as normalized SOD, CAT, GSH-Px and GSH levels, by improving the antioxidant defense system [72] .
Herbicides
Herbicides are widely used for controlling undesirable weeds [73] .
Atrazine
Atrazine, a triazine herbicide, is commonly used for control of grassy weeds in maize, sorghum and sugarcane. Atrazine functions as a photosynthesis blocker. It is a potential pollutant of surface and ground water [74] . It has been reported that lycopene (10 mg/kg/day, orally, for 4 weeks) administration in rats, has a protective effect against oxidative damage in the adrenal cortex induced by atrazine (300 mg/kg/day, orally, for 4 weeks) through restoration of antioxidant defense and alteration of the Nrf2/HO-1 signaling pathway reducing both NF-κB and caspase-3 gene expression [75] . It also has been suggested that lycopene (5 mg/kg, orally, for 21 days) has a hepatoprotective effect on liver injury induced by atrazine (50 or 200 mg/kg, orally, for 21 days) in mice. This protective effect has been suggested to be exerted via regulation of the ionic homeostasis disorder through modulation of ATPase activity and subunits (1a1, 1b3, 1b4, and 2b4) transcription [76] . Moreover, similar studies have reported the potential protective effect of lycopene (5 mg/kg, orally, for 21 days) against atrazine (50 or 200 mg/kg, orally, for 21 days) stimulated cardiotoxicity in a mouse model [77] . Nan Li et al. showed that supplementation of mice with lycopene regulated NO production, inactivated the Tumor necrosis factor receptor-associated factor 6 (TRAF6-NF-kB) pathway as well as up-regulated TNF-α, IL-6, cyclooxygenase 2 (COX-2), and IL-1β and down-regulated the transforming growth factor beta 1 (TGF-β) [78] . In addition, lycopene has been reported to have a hepatoprotective effect against atrazine induced increases in total cytochrome b5 (Cyt b5) in male Kunming mice. Lycopene (5 mg/kg, orally, for 21 days) administration to male Kunming mice modulated the activity of hepatic CYP450s enzymes and normalized the expression of four CYP450s genes for CYP1b1, CYP2a4, CYP2e1, and CYP4A14 [79] . In another study in rats, the protective effect of lycopene against oxidative stress and autophagy induced by atrazine was investigated. In this study, lycopene inhibited the activation of autophagy including LC3II/LC3I ATGs, Belin, and p62 through Nrf2 signaling pathway activation [80] . The evidences presented here, indicate the protective role of lycopene against pesticides toxicity. Administration of lycopene as one of the most effective antioxidants in the carotenoid family, ameliorates pesticides-induced oxidative stress by decreasing lipid peroxidation and by altering the antioxidant defense system. Other mechanisms including modulation of the activity of hepatic CYP450s enzymes and regulation of immune system activity are also involved. Although, more investigations are necessary to elucidate the exact mechanism of lycopenemediated protection against pesticide toxicity and the potential usefulness of this compound.
Cardiotoxic agents
Doxorubicin Doxorubicin (DOX), a chemotherapeutic agent, is in antitumor antibiotic family of drugs which interferes with DNA function. Severe side effects include allergic reactions, renal toxicity, and treatment-related leukemia has been reported in patients receiving DOX [93] . The major side effects, however, is cardiotoxicity which may result in congestive heart failure [81] . In one study, the effects of tomato extract (1.2 and 2.4 g/kg, i.p.) and lycopene (1.7 and 3.5 mg/kg, i.p) on DOX (15 mg/kg, single dose, i.p) stimulated myocardial toxicity were investigated in mice. Treatment with lycopene as well as an aqueous tomato extract was cardioprotective apparently by reducing creatine phosphokinase (CPK) activity thus improving cardiac inflammation [82] . Echocardiogram and morphological examinations showed that doxorubicin (4 mg/kg, body weight, i.p) induced myocyte injury in male Wistar rats which was significantly inhibited by lycopene (5 mg/kg/day, body weight, orally, a 7-week period) without preventing accumulation of interstitial collagen. Also, lycopene had no effects on cardiac dysfunction [83] . Yilmaz et al. determined the effects of lycopene (4 mg/kg, orally) on Adriamycin (trade name for doxorubicin) (10 mg/kg, i.p) induced cardiotoxicity and nephrotoxicity. Their findings indicated that post-injection treatment with lycopene normalized creatinine and urea levels in plasma. The MDA, GSH and CAT activities also were normalized and no histopathological Yonar [72] alterations were reported in heart and kidneys [84] . It has been reported that tomato-oleoresin (5 mg/kg, body weight, orally) has a protecting affect against DOX (4 mg/kg, body weight, i.p) induced cardiac oxidative DNA damage. In this report, DOX maintained lycopene levels in the myocardium of lycopenesupplemented rats and the induced cardiac myocytes DNA damage was reduced by the tomato-oleoresin supplementation. However, the DOX induced cytotoxicity and mortality were not reduced by the tomato-oleoresin supplementation [85] .
In conclusion, the protective effects of Lycopene against DOX-induced heart toxicity have been showed in four animal studies. However, before a conclusive statement on the potential usefulness of lycopene as an adjunct therapy to DOX, there is a need for more studies, including human trials.
Isoproterenol
Isoprenaline, or isoproterenol, is a non-selective β adrenoreceptor agonist which used for cure of bradycardia, heart blockage, and sometimes for asthma. In large doses, isoproterenol (ISO) has been reported to cause myocardial infarction [86, 87] . Mohamadin et al. [4] have shown that dietary lycopene (4 mg/kg, orally, once daily for 21 days) had a protective effect on the cardiotoxicity induced by ISO in rats (85 mg/kg, s.c., once daily for 2 days). Results from this study showed that the lycopene supplement fed to ISO rats improved lysosomal injury, modified alterations in the lipid profile and in the oxidative stress markers and the activity of AST, LDH, creatine kinase-MB (CK-MB), and cardiac troponinT(cTnT), biomarkers of cardiacotixicity, were decreased. Upagenlawar et al. showed that in rats with ISO (200 mg/kg, s.c., for 2 days) induced myocardial infarction there was a decrease in caspase 3 protease function and DNA injury in rats fed lycopene (10 mg/kg/day, orally, for 30 days). Lycopene supplementation reduced CRP levels and MPO activity indicating a potential anti-inflammatory role for lycopene. In addition, lycopene improved the hemodynamic profile including diastolic, systolic, and mean blood pressure. As a result, it has been suggested that lycopene may have beneficial effects in the treatment of ISO-induced myocardial infarction. (Table 3 ) [88] .
Protective effect of lycopene against various neurotoxic agents
Glutamate
Glutamate is a neurotransmitter. Characterized receptors for glutamate belongs to three major classes, AMPA, NMDA, and metabotropic glutamate receptors. Another class of receptors, kainate receptors, are similar in many respects to AMPA receptors. The central nervous system induced toxicity of glutamate is related to production of ROS [89] . The effects of lycopene (10 mg/kg, body weight/day, for 4 weeks) on neurotoxicity induced by monosodium glutamate (5 mg/kg, body weight/day, for 4 weeks) in rats were investigated. In the lycopene-treated group, the oxidative injury, lipid peroxidation levels, the biochemical serum profile (LDH, CPK, and CPK-BB) and cholinesterase activity were repaired. Lycopene also protected against monosodium glutamate-induced brain tissue damage by suppressing apoptosis indicating inhibition of down-regulation of Bcl2 [5] .
N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a potent neurotoxicant, causes Parkinson disease in man and nonhuman primates [90] . MPTP is converted to MPP1 (1-methyl-4-phenylpyridinium) by monoamine oxidase B which induces BioFactors dopaminergic cells damage [91] . It has been reported that lycopene (5, 10, and 20 mg/kg/day, orally) reduced symptoms in a mouse Parkinson disease model induced by MPTP (30 mg/kg body weight, i.p) by increasing Bcl-2 and decreasing bax, caspase 3, 8, and 9, markers of apoptosis signaling pathways. Lycopene also has been reported to have a protective effect on striatal dopamine (DA) and its metabolites following induction by MPTP. In addition, lycopene suppressed oxidative stress and motor abnormalities in the same mouse mode [9] . Yi et al. reported the effects of lycopene (0.5, 1.0, 2.0, or 4.0 μM for 2 h) against MPP1 (500 μM for 24 h) induced cytotoxicity in human neuroblastoma SH-SY5Y cells. These data suggested that lycopene evokes its protective effects by improving mitochondrial dysfunction, apoptosis and by decreasing the accumulation of ROS as well as LPO levels [92] .
6-Hydroxydopamine
6-Hydroxydopamine, a synthetic neurotoxic agent, exerts its effects by activation of the Fenton reaction which leads to production of free radicals [93] . The protective effect of lycopene on 6-Hydroxydopamine (1 μg/μl injected into the SNc) stimulated neurotoxicity in a rat model of Parkinson disease(PD) might be associated with suppressing the degeneration of dopamine-including neurons in the substantia nigra pars compacta (SNc) [94] .
Amyloid β
Amyloid beta (Aβ) peptide constitutes the main component of senile plaques. This protein which is involved in the neuropathology of Alzheimer disease [95] is toxic to the nervous system. Oxidative stress-related to one or several apoptotic pathways has been suggested as a possible mode of action [96] . Lycopene (0.1, 0.5, 1, 2, or 5 μM, for 4 h) added to medium containing cultured rat cortical neurons reduced ROS and mitochondrial superoxide production that had been induced by Aβ (10 μM) [97] . The data further suggested that lycopene (0.1-10 μM for 4 h) may play a protective role against the neurotoxicity induced by β-Amyloid (25 μM) via suppression of oxidative injury. Lycopene also increased the expression of antiapoptotic Bcl-2, reduced the expression of proapoptotic Bax, and inhibited the activation of caspase-3 [96] .
Protective effect of lycopene against the various hepatotoxic agents
Acetaminophen Acetaminophen (N-acetyl-p-aminophenol, APAP) is an analgesic and antipyretic drug. Liver damage including hepatic necrosis and acute liver failure is caused by overdoses of APAP [98] . It has been shown that lycopene (in a dose-dependent manner, orally) protects against acetaminophen (500 mg/kg, orally) induced liver injury in C57BL/6 mice by ameliorating the redox state and by decreasing LPO markers including thiobarbituric acid reactive substances and the expression of IL-1b and by increasing MMP-2 (gelatinase A) activation and anti-oxidant enzymes including CAT and GSH [99] . Moreover, supplementation with lycopene (10 or 100 mg/kg, orally) appeared to be effective in altering GSSG, GSHT and CAT levels. Supplementation with lycopene decreased oxidative stress which could be related to a reduction in protein carbonylation in acetaminophen (500 mg/kg, orally) induced hepatotoxicity in C57BL/6 mice. Lycopene has also been reported to suppress production of ROS in SK-Hep1 cells [6] .
Carbon tetrachloride
Carbon tetrachloride (CCl 4 ) causes liver injury in experimental animals which is associated with its metabolite CCl 3 as a free radical that leads to lipid peroxidation [100] . In the study by Pinto et al., it was shown that lycopene (0.35, 0.65, 1.30 mg/kg, body weight, orally) was chemoprotective against carbon tetrachloride (2.5 ml/kg i.p) induced acute liver damage in rats. A significant increase was observed in the activity of SOD, CAT and GPx and the concentration of GSH, with a reduction in lipoxygenase activity in lycopene-treated rats [101] .
, a polychlorinated aromatic hydrocarbon, is a known human carcinogen and an hepatic toxicant [102] . In this regard, the effects of lycopene (20 μM, for 1 h) against liver microsomal toxicity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (15 nM for 1 h) were evaluated in rat liver. TCDD decreased LPO and H 2 O 2 production, regulated thiol and carbonyl content and reversed the profiles of superoxide dismutase, GPx, CAT, glutathione-S-transferase, and GSH [103] .
Protective effect of lycopene against nephrotoxicants
Gentamicin
Gentamicin, an aminoglycoside antibiotic, is widely used against gram negative bacteria [104] . The nephrotoxicity of gentamicin has been related to hydroxyl radicals and oxidative stress [105] . Pre-treatment with lycopene (4 mg/kg/day) had no effect on the biochemical and oxidative stress profile in gentamicin (100 mg/kg/day) treated rats; however, simultaneous treatment with lycopene reduced the urea and creatinine levels and markedly increase GSH, GSH Px, and CAT [8] .
Cisplatin
Cisplatin is a potent antineoplastic drug. The untoward effects of cisplatin include chromosomal damage [106] , hepatotoxicity [107] , and nephrotoxicity [108] . Cisplatin can elevate the inflammatory response, oxidative stress and renal vasculature injury as well as diminished glomerular filtration [109] in human. In one study in rats, the effects of lycopene (6 mg/kg, body weight, orally) on cisplatin (7 mg/kg, body weight, i.p) induced nephrotoxicity was evaluated. Lycopene decreased serum urea and creatinine levels. A reduction in efflux transporters MRP2 and MRP4 and upregulation of OAT1, OAT3, OCT1, and OCT2 also was observed after lycopene exposure [7] . Similar studies have showed that lycopene can decreased inflammation by suppression of NF-κB P65, and attenuated nephrotoxicity induced by cisplatin through modulating of the Nrf2/HO-1 signaling pathway [110] . Cyclosporine a Cyclosporine A (CsA) is a lipophilic compound which is used as an immunosuppressive agent after transplantation and in the treatment of autoimmune diseases [111] . One of the side effects of CsA, nephrotoxicity, limits it use [112] . As an anti-oxidant, lycopene may have a protective effect on CsA stimulated oxidative stress and renal injury. Lycopene has been reported to decrease urea and creatinine in the plasma and to ameliorated tubular degeneration, necrosis, inter-tubular fibrosis and thickening of the basement membrane in rats [113] . In addition, the use of lycopene (40 mg/kg/day, orally, for 5 days before and 10 days concomitant with CsA injection) in rats, reduced renal injury induced by CsA (15 mg/kg/day, i.p, for 10 days) as suggested by a decrease in the serum concentrations of urea and creatinine, the increase in SOD and GPx and the suppression of MDA. In addition, lycopene restored the GSH content in kidney tissue [114] .
Colistin
The clinical use of colistin, a polymyxin glycopeptide antimicrobial agent produced by certain strain of Bacillus polymixa [115] , is limited because of its nephrotoxicity [130] . Cotreatment of colistin (15 mg/kg/day, i.v.) with lycopene (20 mg/kg/day, body weight, orally) in mice, significantly upregulated Nrf2 and HO-1 mRNA expression and down regulated the expression of NF-κB mRNA which can functions as a free radical and singlet-oxygen scavenger in renal toxicity. These data suggest that lycopene might have some protective effect against colistin induced nephrotoxicity [116] .
Methotrexate
Methotrexate (MTX), a class of antifolates, is widely used as an anti-cancer and immunosuppressive drug in the treatment of malignancies and inflammatory diseases. The nephrotoxicity caused by MTX has been attributed to oxidative stress and inflammation [117] . Oguz et al. showed that lycopene (10 mg/kg, orally) and melatonin (40 mg/kg. i.p) treatment decreased NO levels in rats suffering from renal injury induced by MTX (20 mg/kg, i.p). The histopathological evaluation indicated that there was significant improvement in the tubular dilation and cell swelling. These protecting effects against renal injury induced by MTX may be associated with the antioxidant and anti-inflammatory actions of lycopene [118] . Table 4 represents the effects of lycopene against organtoxic agents in reported previous studies.
Clinical studies
Several clinical trials have suggested that lycopene reduces biomarkers of lipid peroxidation and protein oxidation. For example, lycopene supplementation decreased DNA injury, protein and LDL oxidation in healthy volunteers. It also was reported to decrease LDL oxidation in Type 2 diabetic subjects and to reduce prostate-specific antigen (PSA), tumor burden and increase gene expression of connexin in patients with prostate cancer [119] . The effects of lycopene on the progression of prostate cancer have been studied [120] [121] [122] . In a 1999 placebocontrolled trial, 578 men with developed prostate cancer were followed for 13 years. [123] . Kucuk and his colleagues designed a Phase II randomized clinical trial of lycopene supplementation prior to radical prostatectomy. Twenty six men with localized prostate cancer received twice daily 15 mg of lycopene for 3 weeks before radical prostatectomy. Insulin-like growth factor 1 (IGF-1), IGF binding protein-3, prostate-specific antigen and plasma levels of lycopene were measured at baseline and after 3 weeks. The result showed that prostate-specific antigen levels decreased by 18% and the expression of connexin 43 in cancerous prostate tissue was increased compared to control group [124] . In another study to clarify the efficacy of lycopene and soy isoflavones on serum PSA levels in men who developed prostate cancer, lycopene and soy isoflavones were reported to delay the development of hormone-sensitive and hormonerefractory prostate cancer [125] . Lycopene has been shown to have an effect on cardiovascular disease (CVD) risk factors including inflammation, oxidative stress, blood pressure, lipid metabolism, and endothelial function [126, 127] . A metaanalysis suggested that 25 mg/day lycopene consumption lead to LDL cholesterol reduction of about 10% compared to low doses of statins [141] . The overall summary of 1189 publications indicated that a tomato intervention was associated with significant reductions in LDL-cholesterol and IL-6, flowmediated dilation (FMD) improvement and reduced systolic blood pressure. Moreover the available evidence on the effects of lycopene supplementation on CV risk factors supports the view that increasing the intake of lycopene has a positive effect on blood lipids, blood pressure and endothelial function [144] . In a recent systematic review and meta-analysis, it was reported that the highest consumption category with the highest serum concentration of lycopene had significantly lower risk of stroke (26%), mortality (37%), and CVDs (14%), but limited or no association of lycopene with atherosclerosis, congestive heart failure or atrial fibrillation. Lycopene was not significantly associated with myocardial infarction [128] . Hereafter, more reliable clinical trials, consisting of welldesigned clinical trials, are clearly necessary using larger and longer studies to better delineate the therapeutic role of Lycopene in human.
Conclusion
Various in vitro, in vivo, and clinical studies investigating the protective effect of lycopene against a variety of toxicants suggest potential protective effects of lycopene against mycotoxins, bacterial toxins, metals, fluoride, pesticides, cardiotoxic, neurotoxic, hepatotoxic, and nephrotoxic chemical agents. The protective impact of lycopene was principally attributed to its anti-oxidative, free-radical scavenging, chelating and antiapoptotic properties, each of which has the potential to modify the inflammatory response. However, more clinical trials are required to verify the efficacy of lycopene in human as a protective agent against these inflammatory responses.
